Metrion Biosciences
PrivateLast Round
VC Round
Dec 4, 2023
Total Funding Raised
$1.49M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Metrion Biosciences operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a VC Round in December 2023.
Metrion Biosciences is a contract research organization that provides ion channel drug discovery, cardiac safety screening, and neuroscience services.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Metrion Biosciences Comparables
Compare Metrion Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| B'SYS GmbH | 85% | |
| ApconiX | 83% | |
| Neuroservices-Alliance | 82% |
For institutional investors. Book with your work email.
Metrion Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 4, 2023 | ||||
| VC Round | Apr 6, 2021 | ||||
| Seed | Mar 14, 2019 | ||||
| Grant | Aug 28, 2018 | ||||
| Grant | Feb 5, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Metrion Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| o2h ventures | Seed |
| Innovate UK | Grant |
| Gresham House Ventures | VC Round |
| Maven Capital Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Open roles increased to 8, 2.5x the trailing average.
- Apr 20, 2026
Monthly visitors increased 58% MoM.
For institutional investors. Book with your work email.
Metrion Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Metrion Biosciences's valuation, stock price, and market status.
Is Metrion Biosciences a public or private company?
Metrion Biosciences is a private company.
What is the current stock price of Metrion Biosciences?
Metrion Biosciences is a private company, so its shares have no public market price. Caplight tracks Metrion Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Metrion Biosciences worth (valuation)?
Valuation information for Metrion Biosciences is not publicly available.
Can I buy Metrion Biosciences stock?
Metrion Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Metrion Biosciences's last funding round?
Metrion Biosciences's most recent funding round was VC Round on December 4, 2023.
Who are the main investors in Metrion Biosciences?
Key investors in Metrion Biosciences include o2h ventures, Gresham House Ventures, Maven Capital Partners.
Will Metrion Biosciences IPO soon?
No public IPO plans have been announced for Metrion Biosciences.
How can I track Metrion Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Metrion Biosciences's shares on secondary markets.